COMP <GO>
SXTP vs EOCN // EV/EBITDA & P/E VALUATION
60 Degrees Pharmaceuticals Inc. (NASDAQ) VS. Eocene Ltd. (NASDAQ) • 15-METRIC TALLY: SXTP 2
— EOCN 1
■ METRIC PARITY
LAST: $0.95 (+11.87%) • MKT CAP: $3.3M
valuation
—
LAST: $3.22 (+0.62%) • MKT CAP: $3.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SXTP VS. EOCN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SXTP | EOCN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 65.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | SXTP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.6 | 43.3 | +5.38 | SXTP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.3M | $3.4M | -$21.5K | EOCN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SXTP REV | EOCN REV | SXTP GROSS % | EOCN GROSS % | SXTP FCF | EOCN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.0M | $0 | 22.3% | — | -$7.0M | -$6.3M |
| FY 2024 | $607.6K | $0 | 36.7% | — | -$5.8M | -$5.9M |
| FY 2023 | $253.6K | $0 | — | — | -$4.5M | -$6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SXTP // BETA —
EOCN // BETA —